Mechanisms controlling pathogen colonization of the gut.

The intestinal microbiota can protect efficiently against colonization by many enteric pathogens ('colonization resistance', CR). This phenomenon has been known for decades, but the mechanistic basis of CR is incompletely defined. At least three mechanisms seem to contribute, that is direct inhibition of pathogen growth by microbiota-derived substances, nutrient depletion by microbiota growth and microbiota-induced stimulation of innate and adaptive immune responses. In spite of CR, intestinal infections are well known to occur. In these cases, the multi-faceted interactions between the microbiota, the host and the pathogen are shifted in favor of the pathogen. We are discussing recent progress in deciphering the underlying molecular mechanisms in health and disease.

[1]  S. Matsumoto,et al.  Effects of fecal microorganisms and their chloroform-resistant variants derived from mice, rats, and humans on immunological and physiological characteristics of the intestines of ex-germfree mice , 1994, Infection and immunity.

[2]  C. Lacroix,et al.  New in vitro colonic fermentation model for Salmonella infection in the child gut. , 2009, FEMS microbiology ecology.

[3]  S. Mazmanian,et al.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[4]  T Midtvedt,et al.  A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Rabsch,et al.  Motility allows S. Typhimurium to benefit from the mucosal defence , 2008, Cellular microbiology.

[6]  G. Michel,et al.  Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota , 2010, Nature.

[7]  S. Akira,et al.  Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis , 2009, Gut.

[8]  R. Freter,et al.  Function of Various Intestinal Bacteria in Converting Germfree Mice to the Normal State , 1972, Infection and immunity.

[9]  N. Salzman,et al.  Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella Infection , 2009, Infection and Immunity.

[10]  M. Hogardt,et al.  Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host , 2003, Infection and Immunity.

[11]  R. Freter,et al.  Control of Escherichia coli populations by a combination of indigenous clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures , 1989, Infection and immunity.

[12]  D. Relman,et al.  An ecological and evolutionary perspective on human–microbe mutualism and disease , 2007, Nature.

[13]  J. Koopman,et al.  'Normalization' of germfree mice after direct and indirect contact with mice having a 'normal' intestinal microflora , 1986, Laboratory animals.

[14]  E. Denou,et al.  A Mesocosm of Lactobacillus johnsonii, Bifidobacterium longum, and Escherichia coli in the mouse gut. , 2009, DNA and cell biology.

[15]  R. Freter,et al.  Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure. , 1969, Applied microbiology.

[16]  Wolf-Dietrich Hardt,et al.  Self-destructive cooperation mediated by phenotypic noise , 2008, Nature.

[17]  N. Barnich,et al.  CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. , 2007, The Journal of clinical investigation.

[18]  B. Finlay,et al.  Antibiotic-Induced Perturbations of the Intestinal Microbiota Alter Host Susceptibility to Enteric Infection , 2008, Infection and Immunity.

[19]  Jeffrey N. Weiser,et al.  Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.

[20]  Annaïg Lan,et al.  The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. , 2009, Immunity.

[21]  R. Guigó,et al.  Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. , 2010, Genome research.

[22]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[23]  J. Mekalanos,et al.  In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation , 2010, Proceedings of the National Academy of Sciences.

[24]  R. Dubos,et al.  Enumeration of the Oxygen Sensitive Bacteria usually Present in the Intestine of Healthy Mice , 1968, Nature.

[25]  J. Sirard,et al.  The Microbiota Mediates Pathogen Clearance from the Gut Lumen after Non-Typhoidal Salmonella Diarrhea , 2010, PLoS pathogens.

[26]  K. Wilber,et al.  The Eye of Spirit: An Integral Vision for a World Gone Slightly Mad , 1997 .

[27]  N. Salzman,et al.  Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin , 2003, Nature.

[28]  D. Haller,et al.  Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. , 2010, International journal of medical microbiology : IJMM.

[29]  Wolf-Dietrich Hardt,et al.  The role of microbiota in infectious disease. , 2008, Trends in microbiology.

[30]  D. van der Waaij,et al.  Study of colonization resistance for Enterobacteriaceae in man by experimental contamination and biotyping as well as the possible role of antibodies in the clearance of these bacteria from the intestines , 1991, Epidemiology and Infection.

[31]  C. Jobin,et al.  The struggle within: Microbial influences on colorectal cancer , 2011, Inflammatory bowel diseases.

[32]  E. Bambirra,et al.  Intragastric infection of germfree and conventional mice with Salmonella typhimurium. , 1989, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[33]  Jeffrey I. Gordon,et al.  Reciprocal Gut Microbiota Transplants from Zebrafish and Mice to Germ-free Recipients Reveal Host Habitat Selection , 2006, Cell.

[34]  C. Josenhans,et al.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models , 2010, Nature Reviews Microbiology.

[35]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[36]  J. Gordon,et al.  A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Hooper,et al.  Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin , 2006, Science.

[38]  R. van der Meer,et al.  Salmonella induces prominent gene expression in the rat colon , 2007, BMC Microbiology.

[39]  K. Itoh,et al.  Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota , 2007, Antonie van Leeuwenhoek.

[40]  Benjamin P. Westover,et al.  Glycan Foraging in Vivo by an Intestine-Adapted Bacterial Symbiont , 2005, Science.

[41]  D. van der Waaij,et al.  Determination of colonization resistance of the digestive tract by biotyping of Enterobacteriaceae , 1990, Epidemiology and Infection.

[42]  A. Macpherson,et al.  Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria , 2004, Science.

[43]  B. Skelly,et al.  Effect of a Clostridium Species Upon Cecal Size of Gnotobiotic∗ Mice.† , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  C. von Mering,et al.  Like Will to Like: Abundances of Closely Related Species Can Predict Susceptibility to Intestinal Colonization by Pathogenic and Commensal Bacteria , 2010, PLoS pathogens.

[45]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[46]  B. Finlay,et al.  Gut microbiota in health and disease. , 2010, Physiological reviews.

[47]  G. Weinstock,et al.  Enteric defensins are essential regulators of intestinal microbial ecology , 2009, Nature Immunology.

[48]  R. van der Meer,et al.  Gene expression response of the rat small intestine following oral Salmonella infection. , 2007, Physiological genomics.

[49]  Jeffrey I. Gordon,et al.  Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Michael D. George,et al.  Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. , 2009, Cell host & microbe.

[51]  T. Mitsuoka,et al.  Production of gnotobiotic mice with normal physiological functions. I. Selection of useful bacteria from feces of conventional mice. , 1980, Zeitschrift fur Versuchstierkunde.

[52]  J. Roth,et al.  Gut inflammation provides a respiratory electron acceptor for Salmonella , 2010, Nature.

[53]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[54]  G. Dougan,et al.  Salmonella enterica Serovar Typhimurium Exploits Inflammation to Compete with the Intestinal Microbiota , 2007, PLoS biology.

[55]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[56]  K. Wilson,et al.  Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. , 1986, The Journal of infectious diseases.

[57]  Thomas F. Tedder,et al.  Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism , 2009, Science.

[58]  G. Plitas,et al.  MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection , 2007, The Journal of experimental medicine.

[59]  B. Haas,et al.  A Catalog of Reference Genomes from the Human Microbiome , 2010, Science.

[60]  Samuel I. Miller,et al.  LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.

[61]  Paul S. Cohen,et al.  Comparison of Carbon Nutrition for Pathogenic and Commensal Escherichia coli Strains in the Mouse Intestine , 2008, Infection and Immunity.

[62]  J. Faith,et al.  Dissecting the in Vivo Metabolic Potential of Two Human Gut Acetogens , 2010, The Journal of Biological Chemistry.

[63]  D. van der Waaij,et al.  Determination of the colonization resistance of the digestive tract of individual mice , 1974, Journal of Hygiene.

[64]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[65]  M. Fons,et al.  Production of an antibacterial substance in the digestive tract involved in colonization-resistance against Clostridium perfringens. , 2010, Anaerobe.

[66]  N. Salzman,et al.  Enteric Salmonellosis Disrupts the Microbial Ecology of the Murine Gastrointestinal Tract , 2007, Infection and Immunity.

[67]  R. Dubos,et al.  INDIGENOUS, NORMAL, AND AUTOCHTHONOUS FLORA OF THE GASTROINTESTINAL TRACT , 1965, The Journal of experimental medicine.

[68]  Bernard Henrissat,et al.  Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla , 2009, Proceedings of the National Academy of Sciences.

[69]  J. Gilsdorf,et al.  Conceptualizing Human Microbiota: From Multicelled Organ to Ecological Community , 2008, Interdisciplinary perspectives on infectious diseases.

[70]  Tomohiro Watanabe,et al.  The Molecular Basis of NOD2 Susceptibility Mutations in Crohn's Disease , 2008, Mucosal Immunology.

[71]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[72]  J. Parkhill,et al.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota , 2011, The ISME Journal.

[73]  D. van der Waaij,et al.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. , 1971 .

[74]  D. C. Cara,et al.  Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis , 2010, Archives of Microbiology.

[75]  Rob Knight,et al.  Identifying genetic determinants needed to establish a human gut symbiont in its habitat. , 2009, Cell host & microbe.

[76]  Ronald P. DeMatteo,et al.  Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits , 2008, Nature.

[77]  J. Roth,et al.  Virulence Mechanisms of Bacterial Pathogens , 1995 .

[78]  J. Hudson,et al.  Bacteria Induced Morphologic Changes.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[79]  Bernard Henrissat,et al.  Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins , 2010, Proceedings of the National Academy of Sciences.

[80]  Janne Nikkilä,et al.  Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. , 2010, Journal of microbiological methods.

[81]  V. Kunin,et al.  Wrinkles in the rare biosphere: pyrosequencing errors can lead to artificial inflation of diversity estimates. , 2009, Environmental microbiology.

[82]  Maria Karlsson,et al.  Creating and characterizing communities of human gut microbes in gnotobiotic mice , 2010, The ISME Journal.

[83]  Maria Karlsson,et al.  Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. , 2010, Cell host & microbe.

[84]  D. Relman,et al.  Host Transmission of Salmonella enterica Serovar Typhimurium Is Controlled by Virulence Factors and Indigenous Intestinal Microbiota , 2007, Infection and Immunity.

[85]  J. Gordon,et al.  Commensal Host-Bacterial Relationships in the Gut , 2001, Science.

[86]  J. Nicoli,et al.  Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection , 2011, Medical Microbiology and Immunology.

[87]  R. Dubos,et al.  THE DEVELOPMENT OF THE BACTERIAL FLORA IN THE GASTROINTESTINAL TRACT OF MICE , 1965, The Journal of experimental medicine.

[88]  N. Fairweather,et al.  Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts , 2009, Infection and Immunity.

[89]  Paul S. Cohen,et al.  Precolonized Human Commensal Escherichia coli Strains Serve as a Barrier to E. coli O157:H7 Growth in the Streptomycin-Treated Mouse Intestine , 2009, Infection and Immunity.

[90]  J. Gordon,et al.  A Model of Host-Microbial Interactions in an Open Mammalian Ecosystem , 1996, Science.

[91]  B. Stecher,et al.  Comparison of Salmonellaenterica Serovar Typhimurium Colitis in Germfree Mice and Mice Pretreated with Streptomycin , 2005, Infection and Immunity.

[92]  M. Kleerebezem,et al.  Lifestyle of Lactobacillus plantarum in the mouse caecum. , 2009, Environmental microbiology.

[93]  W. Moore,et al.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians. , 1974, Applied microbiology.

[94]  F. Dewhirst,et al.  Phylogeny of the Defined Murine Microbiota: Altered Schaedler Flora , 1999, Applied and Environmental Microbiology.

[95]  K. Schleifer,et al.  The domain-specific probe EUB338 is insufficient for the detection of all Bacteria: development and evaluation of a more comprehensive probe set. , 1999, Systematic and applied microbiology.

[96]  H. Blöcker,et al.  Charles River altered Schaedler flora (CRASF®) remained stable for four years in a mouse colony housed in individually ventilated cages , 2009, Laboratory animals.

[97]  M. Bohnhoff,et al.  Effect of Streptomycin on Susceptibility of Intestinal Tract to Experimental Salmonella Infection.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[98]  M. Heikenwalder,et al.  The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. , 2009, Cell host & microbe.

[99]  J. Gordon,et al.  Genomic and Metabolic Studies of the Impact of Probiotics on a Model Gut Symbiont and Host , 2006, PLoS biology.

[100]  K. Itoh,et al.  16S rRNA gene sequence‐based analysis of clostridia related to conversion of germfree mice to the normal state , 2009, Journal of applied microbiology.

[101]  J. Koopman,et al.  'Normalization' of germfree mice with anaerobically cultured caecal flora of 'normal' mice , 1984, Laboratory animals.

[102]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[103]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[104]  A. Imaoka,et al.  Segmented Filamentous Bacteria Are Indigenous Intestinal Bacteria That Activate Intraepithelial Lymphocytes and Induce MHC Class II Molecules and Fucosyl Asialo GM1 Glycolipids on the Small Intestinal Epithelial Cells in the Ex‐Germ‐Free Mouse , 1995, Microbiology and immunology.

[105]  T. Midtvedt,et al.  Intestinal microflora functions in laboratory mice claimed to harbor a "normal" intestinal microflora. Is the SPF concept running out of date? , 2010, Anaerobe.

[106]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[107]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[108]  R. Freter,et al.  Efficiency of Various Intestinal Bacteria in Assuming Normal Functions of Enteric Flora After Association with Germ-Free Mice , 1970, Infection and immunity.